Sign In
Last checked at 
1 May 2020 09:19
1 May 2020
Kainos Group plc
("Kainos" or the "Company")Ā
Total Voting Rights
Ā
Pursuant to DTR 5.6.1 the Company announces that as at 1 May 2020, the total number of ordinary shares in issue now stands at 122,098,488 each with voting rights. There are no shares held in treasury.
Ā
The above figure (122,098,488) may be used by shareholders as the denominator for the calculations by which they will determine if they are required to notify their interest in, or a change in their interest in, the Company under the FCA's Disclosure and Transparency Rules.
Ā
Kainos Group plc Legal Entity Identifier: 213800H2PQMIF3OVZY47Ā
Classification: 2.5 - Total number of voting rights and capital
Ā
Ends
For further information, please contact:
Ā
Kainos via FTI Consulting LLP
Brendan Mooney, Chief Executive Officer
Richard McCann, Chief Financial Officer
Ā
Investec Bank plc +44Ā 20 7597 5970
Patrick Robb / Ben Griffiths
Ā
Canaccord Genuity +44 20 7523 4606
Simon Bridges/ Andrew Potts
Ā
FTI Consulting LLP +44 20 3727 1000
Matt Dixon / Kwaku Aning / Leah Dudley
Ā
About Kainos
KainosĀ Group plc is a UK-headquartered provider of Digital Services and Digital Platforms.Ā
Ā
The Group's Digital Services include full lifecycle development and support ofĀ customisedĀ Digital Services for government and commercial customers.Ā KainosĀ is also the leading European partner for Workday, Inc. ('Workday'), responsible for implementing Workday's innovative Software-as-a-Service (SaaS) platform for enterprise and, now, government customers.Ā
Ā
The Group's Digital Platforms compriseĀ specialisedĀ digital platforms in the mobile healthcare and automated testing arenas. Smart is an automated testing platform for Workday customers; Evolve Electronic Medical Records ('EMR') is the market-leading product for theĀ digitisationĀ of patient notes in the Acute sector of the NHS.
Ā
Kainos has over 1,700 people across 12 offices in Europe and North America.
KainosĀ is listed on the London Stock Exchange (LSE: KNOS). For further information, please visitĀ www.kainos.com.
Ā
Follow the stocks
